Fortress Biotech (FBIO) Receives $10.67 Average Price Target from Analysts

Fortress Biotech (FBIO) Receives $10.67 Average Price Target from Analysts

Fortress Biotech has been assigned an average rating of "Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.

from Biotech News